Recent Articles from Investor Brand Network

A newly released federally backed study suggests that many older Americans are turning to cannabis not for recreation, but in search of relief after struggling with traditional medical treatments.

Titan Partners, a division of American Capital Partners, has appointed Scott Buck, Kyle Bauser, Ph.D., and Adam Kelsey, CFA, to significantly expand its equity research platform across technology, healthcare, and energy, power and infrastructure. The three analysts bring more than 40 years of combined middle-market equity research experience, strengthening Titan’s sector-focused research capabilities as the firm continues to build its investment banking platform focused on underfollowed small- and mid-cap public companies.

AI Maverick Intel (OTC: AIMV) announced the issuance of 76.5 million common shares to HEAL Group Holdings as the initial tranche of consideration under the companies’ Right of First Refusal Agreement dated Feb. 11, 2026, as AIMV advances its proposed acquisition of HEAL Access Canada Inc. The company said the total consideration tied to the transaction has been adjusted from 120 million to 100 million AIMV common shares, with the parties continuing toward a definitive agreement, while also noting plans to pursue an uplisting to the OTCQB Venture Market as part of its broader capital markets strategy.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Growing demand for artificial intelligence sparked gains across three corners of the technology sector on Thursday, May 8, highlighting how investment tied to AI is expanding beyond graphics processors and into the wider digital infrastructure ecosystem.

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement.

The copper market has remained on edge as geopolitical risks stoke volatility . As a result, prices have swung widely in response to news headlines. According to an analysis published by ING, the current market behavior is driven more by political news rather than the usual market fundamentals.

Bullish (NYSE: BLSH) has entered into a definitive agreement to acquire Equiniti, the parent company of Notified and a global transfer agent and shareholder services provider, in a transaction valued at $4.2 billion. The acquisition is designed to position Bullish at the forefront of blockchain-native capital markets infrastructure by combining its institutional digital asset platform with Equiniti’s regulated transfer agent capabilities, which support nearly 3,000 public companies and more than 20 million verified shareholders.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

Pairing solar and wind with battery storage already delivers electricity at prices that match new coal and beat new gas costs across much of the world, according to a recent International Renewable Energy Agency report . The findings address one of the most enduring objections to renewable power: that intermittent generation makes clean energy unsuitable as a reliable primary source.

Gold’s behavior in 2026 has surprised many investors. Traditionally, geopolitical conflict in the Middle East sends investors rushing into safe-haven assets, pushing gold prices higher. But during the current Iran conflict, the opposite has happened . Each major escalation has triggered gold selloffs, while reports of ceasefires or peace negotiations have sparked rallies.

A new survey of German car industry managers suggests the sector is further into its electric vehicle transition than public debate tends to imply, with a small group of slower-moving firms distorting the wider picture and potentially dragging down the broader shift. The research was carried out jointly by the University of Sussex and the Fraunhofer Institute for Systems and Innovation Research, drawing on responses from 74 industry managers gathered toward the end of 2025.

The NHS in England is rolling out a treatment upgrade under which thousands of patients with cancer will now receive a one-minute injection of the immunotherapy pembrolizumab instead of having the drug administered via infusion as has been the case in the past. The jab slashes the administration time from hours to just a minute or two.

An analysis of the semiconductor stocks performing exceptionally well reveals that all these companies provide a product that is regarded as a bottleneck in the AI boom . Several companies help to illustrate this insight.

German automaker Porsche has announced plans to cut more than 500 jobs as the company faces growing financial pressure and slowing demand for electric vehicles. The move is part of a wider restructuring effort aimed at helping the luxury carmaker focus on its main business operations during a difficult period for the global auto industry.

Major crypto exchanges are reportedly stepping up efforts to influence legislation in Washington, seeking changes to a proposed market-structure measure that could significantly affect how digital assets are traded in the U.S.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Lunai Bioworks (NASDAQ: LNAI) is the plaintiff in a federal securities fraud lawsuit filed in Delaware by national law firms Dickinson Wright and Fox Rothschild, alleging that unidentified “naked” short sellers engaged in a coordinated scheme to manipulate trading in the company’s common stock. The complaint alleges repeated violations of SEC Regulation SHO, including failures to deliver shares reaching as high as 234.6 times the maximum baseline daily rate and periods in which failures to deliver allegedly represented 81.6% of the company’s total outstanding shares.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

Tonix Pharmaceuticals (NASDAQ: TNXP) reported first-quarter 2026 financial results while highlighting continued commercial momentum for TONMYA, its recently launched fibromyalgia treatment, and advancement across its clinical pipeline. The company said TONMYA, the first new fibromyalgia medicine in 15 years, has shown growth in prescriptions, prescribers, refills and patient access since its November 2025 launch, with a recently announced managed care agreement expanding potential coverage to approximately 35 million U.S. commercial lives, while pipeline progress included positive Phase 1 data for TNX-4800, a Lyme disease prevention candidate, and plans to begin a Phase 2 study of TONMYA in major depressive disorder later this year.

Lantern Pharma (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, announced that it will report its first-quarter 2026 operating and financial results via press release on May 15. The update will include financial results for the quarter ended March 31, 2026, along with operational updates regarding the company’s clinical trials and development of its proprietary artificial intelligence and machine learning platforms.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in a BioMedWire editorial examining emerging breakthroughs in central nervous system drug delivery and the growing market opportunities tied to overcoming the blood-brain barrier. The editorial highlights Oncotelic’s proprietary intranasal nose-to-brain delivery platform, which is designed to enable rapid, targeted therapeutic access to the brain, positioning the company within a broader industry effort to advance next-generation treatments for neurological disease, biodefense applications and other CNS-related conditions.

In a blog post by Daniel Azoulai, Qdrant highlighted how Sapu , an early-stage biopharmaceutical company developing treatments for hard-to-treat cancers, uses Qdrant Cloud infrastructure to power an AI research platform capable of indexing and querying all 28 million PubMed abstracts in a single searchable collection, helping accelerate biomedical discovery workflows.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

A new report from congressional researchers is shedding light on what the Trump administration’s move to reclassify cannabis could mean for the industry, while also outlining the limits of the policy shift under federal law.

Pershing Square USA (NYSE: PSUS) and Pershing Square Inc. (NYSE: PS) announced the closing of their combined initial public offerings and previously announced combined private placement, generating gross proceeds of $5 billion for PSUS before deducting sales loads, placement fees and offering expenses. The PSUS shares and PSI shares began trading on the New York Stock Exchange on April 29, 2026, under the symbols PSUS and PS, respectively.

Delta Gold Technologies (Aquis: DGQ /OTC:DGQTF) is featured in the debut episode of The Innovation Report Series, a new documentary initiative exploring technologies, industries and companies shaping the future global economy. The first episode, The Quantum Revolution , examines the advancing commercial potential of quantum technologies and their potential impact across industries, while the broader series explores the intersection of innovation, capital markets and industrial transformation. The upcoming second episode will focus on the critical minerals sector and feature Guardian Metal Resources (LSE: GMET) (NYSE American: GMTL) (OTC: GMTLF).

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.

This article has been disseminated on behalf of Oregen Energy Corp. and may include paid advertising.

Twin Vee PowerCats (NASDAQ: VEEE) reported first-quarter 2026 revenue growth of approximately 10% year over year and 31% sequentially, marking its fourth consecutive quarter of year-over-year revenue gains, as the company continued expanding its product lineup with the relaunch of Bahama Boat Works. Twin Vee posted a net loss of $2.09 million, compared with $1.6 million in the prior-year quarter, while adjusted EBITDA loss improved 11% to $776,000. The company said results included approximately $1.3 million in non-cash and one-time items tied to inventory adjustments, product development and field inventory management, while cash and equivalents increased by more than $4 million from the fourth quarter.

Datavault AI (NASDAQ: DVLT) highlighted the strategic positioning of its distributed edge computing network ahead of this week’s anticipated U.S. Senate Banking Committee markup of the Digital Asset Market Clarity Act, legislation aimed at establishing a comprehensive federal framework for digital assets. The company said it expects regulatory clarity to support increased demand for secure data processing, tokenization and AI infrastructure, as it advances deployment of a modular mini data center network targeting more than 100 U.S. metropolitan markets with full commercial availability of a planned 48,000-GPU fleet beginning in the third quarter of 2026.

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG patch in approximately 50 patients with suspected coronary artery disease at two hospitals in Belgrade, Serbia. The study will compare synthesized 12-lead ECG readings generated by the company’s patch immediately following exercise stress testing against standard 12-lead ECGs, supporting HeartBeam’s regulatory strategy for a device designed to expand ambulatory cardiac monitoring beyond rhythm assessment into ischemia detection within an established approximately $2 billion patch-based monitoring market.

In clinical-stage biotechnology, the central challenge is rarely scientific discovery. It is capital. Advancing multiple therapeutic candidates through preclinical work, clinical trials, and regulatory approval requires sustained funding, and traditional financing routes often come at the cost of dilution or loss of asset control. With biotech capital markets remaining selective and the IPO window constrained, alternative models that preserve shareholder value while advancing pipelines are gaining traction.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.

A systematic review in JAMA Network Open suggests earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes in patients being treated for late-stage solid tumors . The analysis pooled data from 29 studies encompassing more than 6,000 patients. Earlier timing was linked to gains in both survival endpoints, though prospective validation is required before scheduling adjustments can be broadly adopted.

Apple has agreed to pay a $250 million settlement in the United States to resolve a lawsuit over its artificial intelligence marketing for recent iPhones. The case focused on claims that the company misled customers about the capabilities and availability of new AI features promoted under the name Apple Intelligence.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to healthcare and public health management. Traditional methods such as breathalyzers, blood tests and urine screenings are often limited by their invasiveness, delayed results or inability to assess real-time impairment, particularly in cases involving multiple substances. As patterns of substance use evolve and the societal costs of impaired behavior continue to rise, the demand for faster, more scalable and noninvasive diagnostic solutions is becoming increasingly urgent. MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) ( Profile ) is advancing a novel approach that leverages artificial intelligence (“AI”) and voice analysis to predict intoxication from short speech samples. By focusing on the human voice as a measurable indicator of internal physiological and cognitive states, the company is working to develop a platform capable of detecting impairment across a range of substances in real-time. This approach not only addresses a critical gap in existing detection methods but also reflects a broader shift toward AI-driven, noninvasive diagnostics with the potential to transform regulatory enforcement, workplace safety and public health outcomes. MindBio joins other key companies operating at the forefront of health, AI and diagnostics technologies, including HeartFlow Inc. (NASDAQ: HTFL), Recursion Pharmaceuticals Inc. (NASDAQ: RXRX), Tempus AI Inc. (NASDAQ: TEM) and…

BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this challenge is the blood-brain barrier (BBB), a biological defense system that prevents most therapeutics from reaching the central nervous system (“CNS”). As Alzheimer’s disease cases rise globally and governments intensify focus on biodefense preparedness, the inability to deliver drugs effectively to the brain is emerging as a critical bottleneck in modern medicine. With this in mind, innovative companies, including Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), are working within a broader industry shift toward advanced delivery platforms designed to bypass traditional barriers and facilitate rapid, targeted access to the brain. Oncotelic’s approach, which includes a proprietary intranasal nose-to-brain (“N2B”) system that enables rapid therapeutic delivery, reflects a growing recognition that solving CNS delivery, not just drug discovery, may be key to unlocking the next generation of therapies. Oncotelic joins a group of leading biopharma companies focused on cutting-edge therapeutic platforms and large-scale drug development in a range of treatment areas, including Biogen Inc. (NASDAQ: BIIB), Moderna Inc. (NASDAQ: MRNA), CytoDyn Inc. (OTCQB: CYDY) and…

AINewsWire Editorial Coverage : The nature of modern warfare is being rewritten in real time, driven by the rapid rise of cheap, mass-produced drones that are reshaping the economics of conflict. In war zones such as Ukraine, millions of low-cost systems, often built in small workshops or adapted from commercial designs, are now performing missions once reserved for advanced aircraft and precision-guided weapons. But while the hardware has become abundant and accessible, a critical limitation has emerged: Most of these drones lack the intelligence to operate independently in contested environments. GPS jamming, electronic warfare and the need for constant human control expose a growing gap between what drones can do and what they need to do to remain effective at scale. Increasingly, defense leaders recognize that the next phase of this revolution will not be defined by better hardware but by better software: the intelligence layer that enables autonomy, navigation, and precision without relying on vulnerable systems. SPARC AI Inc. (OTC: SPAIF) ( Profile ) is positioning itself directly within this shift, developing a software-only platform designed to give any drone, regardless of cost or manufacturer, the ability to operate with GPS-denied navigation and precision targeting. SPARC AI is one of several companies working in the drone, AI and defense-tech space, including leaders such as Swarmer Inc. (NASDAQ: SWMR), Unusual Machines (NYSE American: UMAC), Draganfly Inc. (NASDAQ: DPRO) and…

BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (“T2DM”) have become two of the most pressing healthcare challenges worldwide, driving rising rates of cardiovascular disease, fatty liver disease, kidney complications and escalating healthcare costs. What began as a niche class of diabetes medications has evolved into one of the most transformative therapeutic categories in modern medicine, with GLP-1 receptor agonists now reshaping obesity treatment, metabolic care and potentially even neurodegenerative disease management. Against this backdrop, SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF), ( Profile ) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history. SureNano is one of the emerging microcap companies operating in the GLP space, forming part of a group of companies leading the way in the GLP-1 space, including Eli Lilly and Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Amgen Inc. (NASDAQ: AMGN) and…

Oncotelic Therapeutics (OTCQB: OTLC) is positioning itself within a growing push to overcome one of modern medicine’s most persistent challenges: delivering therapeutics effectively across the blood-brain barrier. Through its proprietary intranasal nose-to-brain delivery platform, the company is pursuing targeted central nervous system applications spanning Alzheimer’s disease and biodefense, reflecting broader industry recognition that delivery technology may be as critical as drug discovery itself. Oncotelic is part of an innovative therapeutic landscape that includes Biogen Inc. (NASDAQ: BIIB), Moderna Inc. (NASDAQ: MRNA), CytoDyn Inc. (OTCQB: CYDY) and Northwest Biotherapeutics Inc. (OTCQB: NWBO).

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

NanoViricides, Inc. (NYSE American: NNVC) highlighted the potential need for broad-spectrum antiviral treatments following the recent Andes hantavirus incident aboard a cruise ship, pointing to its clinical-stage antiviral candidate NV-387 as a potential therapeutic platform for emerging viral threats. The company said NV-387 has completed a Phase I safety and tolerability trial in healthy volunteers and has demonstrated effectiveness in animal models involving multiple viral lung infections, including coronaviruses, RSV, influenza, monkeypox and measles, as it advances development of a platform designed to target a broad range of pathogenic viral infections.

Safe Pro Group (NASDAQ: SPAI) announced it has been invited to train and equip soldiers with its patented SPOTD Edge AI battlefield threat detection system during a U.S. Army Force-on-Force combat training exercise scheduled for the second quarter of 2026. The exercise, one of the Army’s most realistic combat training environments, will allow Safe Pro to demonstrate rapid AI-powered explosive threat identification and enhanced battlefield mapping capabilities in simulated live combat conditions.

Kairos Pharma (NYSE American: KAPA) announced that its annual meeting of shareholders will be held virtually at 9 a.m. PDT on June 29, 2026, with meeting materials to be mailed following finalization and filing with the SEC. The clinical-stage biopharmaceutical company also disclosed that its 2025 annual report included an audit report containing a going concern explanatory paragraph from its independent registered public accounting firm, as required under Section 610(b) of the NYSE American Company Guide, noting the disclosure does not reflect any change or amendment to previously filed financial statements.

Lavish Enterprises (OTC: VXIT) announced it has executed a definitive agreement to acquire exclusive, perpetual and irrevocable commercial rights to FleetPath, an AI-native operating system designed to unify freight lifecycle operations for trucking carriers, brokers, shippers and drivers within a single platform. The company said FleetPath is operational and approaching beta-stage deployment, with initial customer rollouts targeted as the platform enters beta, as Lavish looks to address inefficiencies across the fragmented trucking software market.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Yahoo Finance’s Hal Bundrick explores how crypto-backed mortgages may signal a broader transformation in home financing and tokenized asset lending

Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics division, announced a strategic partnership initiative with ToDo Robotics aimed at accelerating the expansion of its AI-powered automation and Robotics-as-a-Service platform across U.S. commercial markets. ToDo Robotics, which has completed more than 300 robotic system deployments, is expected to contribute deployment infrastructure, customer relationships and operational support, while TechForce plans to provide robotic delivery systems, hospitality automation platforms, AI-enhanced technologies and software integration capabilities.

Greenland Energy (NASDAQ: GLND) is positioning itself within a shifting global energy landscape, as policymakers and industry leaders increasingly look beyond traditional oil-producing regions in search of new, scalable hydrocarbon resources. Years of underinvestment in upstream development, combined with reserve depletion in mature basins and rising geopolitical instability, are driving renewed interest in frontier exploration .

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

A recent federal decision to reclassify medical cannabis is reshaping the outlook for licensed operators, prompting renewed attention from businesses and regulators across the country.

Frontieras is positioned amid increased demand for domesticenergy production. “At the core of its strategy is Frontieras’s FASForm(TM) process, which the company describes as a solid carbon fractionation technology that separates coal into its constituent components,” reads a recent article.

Greenland Energy (NASDAQ: GLND) is an exploration-focused oil and gas company targeting development in the Jameson Land Basin, a large and historically underexplored hydrocarbon region in the Arctic. Formed through the completed business combination of Pelican Acquisition Corporation, Greenland Exploration Limited, and March GL Company, “the company’s vision is to responsibly unlock Greenland’s energy potential, supporting both local development and global energy security through science-driven exploration and innovation,” reads a recent article. “The company is working to progress exploration across the Jameson Land Basin, which has been studied extensively but remains undrilled, combining historical geological work with modern seismic analysis and planned drilling programs. Its efforts are focused on unlocking the hydrocarbon potential identified through decades of prior research while progressing toward initial well development.”

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

This article has been disseminated on behalf of Blue Moon Metals Inc. and may include paid advertising.

Newsmax (NYSE: NMAX) announced that it has surpassed 25 million followers across its social media platforms, reaching 25.4 million total followers as the company continues expanding its digital audience. The milestone comes alongside record audience metrics, including 104.18 million Facebook user reach in the first quarter of 2026, up 44% sequentially and 119% year over year, while the Newsmax App has exceeded 13 million downloads as the company broadens its multi-platform media presence.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Strawberry Fields REIT (NYSE AMERICAN: STRW) reported first-quarter 2026 results showing growth in key operating metrics, with FFO rising to $20.9 million, or $0.38 per share, from $18.3 million, or $0.33 per share, in the prior-year quarter, while AFFO increased to $18.8 million, or $0.34 per share, from $16.8 million, or $0.30 per share. Net income rose to $9.5 million from $7.0 million, rental income increased to $40.0 million from $37.3 million, and the company collected 100% of contractual rents while also signing a term sheet for a $300 million corporate credit facility expected to close in the second quarter to refinance debt and support acquisition growth.

Nightfood Holdings (OTCQB: NGTF) is featured in a NetworkNewsAudio Audio Press Release titled “Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion,” which highlights accelerating adoption across the service robotics sector as advances in artificial intelligence, machine vision and sensor integration drive the shift from conceptual development to real-world deployment. The editorial spotlights Nightfood’s TechForce Robotics unit and its focus on practical hospitality automation solutions designed to deliver immediate operational value as service robotics adoption scales.

Strawberry Fields REIT (NYSE AMERICAN: STRW) announced that its board of directors has declared a quarterly cash dividend of $0.17 per common share. The dividend will be paid on June 30, 2026, to stockholders of record at the close of business on June 16, 2026.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is expanding beyond its core energy initiatives with the launch of a Government Procurement Services operating segment. The move reflects an effort to diversify operational activities while building relationships within defense and institutional procurement channels.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Following January’s surge to record highs, copper prices have entered a more cautious phase, reacting closely to developments surrounding the Iran crisis. The ongoing closure of the Strait of Hormuz presents a paradox for the market, creating both upward and downward pressure on prices.

Norway recorded a 98.6% EV share of new passenger car registrations in April, breaking the prior record of 98.4% set just one month earlier. Of April’s 11,103 registrations, 10,952 were fully electric, while just 87 were diesel and 31 petrol, according to the OFV, Norway’s Road Federation .

Last week, the U.S. Department of Justice announced a plan to tackle tech-driven fraud in the health care system on the West Coast . The initiative will focus on California, Arizona and Nevada. Their investigations will target fraudulent schemes, especially those executed by digital health firms.